Literature DB >> 1999680

Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.

F M Tomas1, S E Knowles, P C Owens, L C Read, C S Chandler, S E Gargosky, F J Ballard.   

Abstract

The ability of insulin-like growth factor-I (IGF-I) to protect against losses of body protein during periods of dietary nitrogen restriction has been evaluated in young rats. Recombinant human IGF-I was administered by osmotic pumps at dose rates of 0, 1.2 or 2.9 mg/kg per day over a 7-day period beginning with the transfer of animals from an 18% to a 4% protein diet. A fourth group received the potent truncated IGF-I analogue, des(1-3)IGF-I, at a dose of 1.2 mg/kg per day over a comparable 7-day period. Plasma IGF-I levels were reduced by 60% following nitrogen restriction, a reduction that was partly prevented by IGF-I administration, especially at the higher dose, but not measurably by des(1-3)IGF-I. The major IGF-binding protein circulating in blood, IGFBP-3, demonstrated a similar pattern of change. A significant (P less than 0.05) protection of body weight was achieved in the low dose IGF-I and des(1-3)IGF-I groups, but only after differences in food intake had been eliminated by analysis of covariance. Nitrogen balances were not significantly different unless analysis of covariance was used to adjust for the nitrogen intakes, whereupon all treatment groups showed improved balance, especially the animals treated with the low IGF-I dose and des(1-3)IGF-I (both P less than 0.01). The rate of muscle protein breakdown calculated from the urinary excretion of 3-methyl-histidine was not significantly altered by the treatments, but fell progressively throughout the 7 days. The fractional rate of muscle protein synthesis measured on the final day was increased by 31,26 and 21% respectively by the low and high doses of IGF-I and by des(1-3)IGF-I. Organ weights (g/kg body weight) showed no effects of IGF-I treatment except for 16% increases in the weight of kidneys in the high dose IGF-I and the des(1-3)IGF-I groups. Carcass analyses demonstrated higher water and lower fat contents (all P less than 0.01) in the same groups. These results suggest that exogenous IGF-I and especially des(1-3)IGF-I can partly protect body protein reserves during nitrogen restriction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999680     DOI: 10.1677/joe.0.1280097

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  14 in total

1.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 2.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

Review 3.  Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study.

Authors:  James Beattie; Kirsten Phillips; John H Shand; Malgorzata Szymanowska; David J Flint; Gordon J Allan
Journal:  Mol Cell Biochem       Date:  2007-09-25       Impact factor: 3.396

4.  Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.

Authors:  Haydn L Atkins; Mark S Geier; Luca D Prisciandaro; Ashok K Pattanaik; Rebecca E A Forder; Mark S Turner; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

5.  Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.

Authors:  H Ding; J D Kopple; A Cohen; R Hirschberg
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil.

Authors:  Suzanne Mashtoub; Ker Y Cheah; Kerry A Lymn; Gordon S Howarth
Journal:  Exp Biol Med (Maywood)       Date:  2018-07-09

7.  Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats.

Authors:  F M Tomas; S E Knowles; P C Owens; C S Chandler; G L Francis; L C Read; F J Ballard
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats.

Authors:  E Southcott; K L Tooley; G S Howarth; G P Davidson; R N Butler
Journal:  Dig Dis Sci       Date:  2008-04-22       Impact factor: 3.199

9.  Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.

Authors:  F M Tomas; C S Chandler; P Coyle; C S Bourgeois; J L Burgoyne; A M Rofe
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  Metabolic response of sheep skin to a chronic infusion of a variant of insulin-like growth factor I.

Authors:  J E Hocking Edwards; S K Khalaf; B R Sinclaire; J Lee; C G Prosser; P M Harris
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.